Alternative medicine

Medicine Man Technologies Launches Online Marketplace for Strategic Partners’ Dispensary Operations

Friday, March 27, 2020 - 9:43pm

Medicine Man Technologies, Inc. (OTCQX:MDCL) ("Medicine Man Technologies" or "the Company") today launched a collective platform to support strategic partners through COVID-19.

Key Points: 
  • Medicine Man Technologies, Inc. (OTCQX:MDCL) ("Medicine Man Technologies" or "the Company") today launched a collective platform to support strategic partners through COVID-19.
  • Medicine Man Technologies has launched a platform to bring together all the Companys strategic partners offerings to one place.
  • Medicine Man Technologies platform enables Colorado consumers to find information and updates for the Companys strategic partners dispensary operations as we all navigate through COVID-19.
  • The Companys dispensary strategic partners include Medicine Man, Starbuds, Colorado Harvest Company, Strawberry Fields, Roots Rx and Mesa Organics.

Sproutly Executes its 3rd and 4th Provincial Supply Agreements with Manitoba and Saskatchewan

Friday, March 27, 2020 - 1:00pm

CALIBER's launch in Manitoba and Saskatchewan will be supported with regional marketing efforts in accordance with Health Canada regulations.

Key Points: 
  • CALIBER's launch in Manitoba and Saskatchewan will be supported with regional marketing efforts in accordance with Health Canada regulations.
  • We are pleased to announce Manitoba and Saskatchewan as our newest partners to carry our CALIBER branded products.
  • With a combined 70 physical retail locations across the two provinces, Manitoba and Saskatchewan will continue push the momentum for the Companys ongoing and ambitious product launch plan, said Keith Dolo, CEO & Director of Sproutly.
  • As we mentioned from the start, our small-batch dried flower is only the very beginning of our CALIBER brand portfolio.

Vyripharm Biopharmaceuticals Is in the Development Stage of a Novel Integrated Theranostic Approach for the Treatment of Viral Infections Such as COVID-19

Friday, March 27, 2020 - 3:40am

This theranostic approach will use radiopharmaceuticals for detection and diagnosis with the ability to incorporate combination therapies to interrupt the replication of the virus.

Key Points: 
  • This theranostic approach will use radiopharmaceuticals for detection and diagnosis with the ability to incorporate combination therapies to interrupt the replication of the virus.
  • The company considers that the drug platform will represent a novel theranostic technology which will establish a precision medicine therapeutic intervention that will be inexpensive and lead to more accurate diagnosis, treatment and evaluation of viral infections.
  • Vyripharm believes that this approach may have the potential to be a dominant novel application tool for the early diagnosis, monitoring, evaluation and treatment of coronavirus.
  • Our company recognized that looking at existing drugs that treat related viral infections would provide a timely approach to developing an effective treatment.

IGC Receives New Patent from U.S. Patent Office to Treat Cachexia and Eating Disorders in Humans and Veterinary Animals

Friday, March 27, 2020 - 12:30am

IGC filed this application for its IGC-504 formulation (#15/751,901) on August 11, 2016.

Key Points: 
  • IGC filed this application for its IGC-504 formulation (#15/751,901) on August 11, 2016.
  • A public copy of the patent is available on the USPTO website.
  • A patent for an invention is the grant of a property right to the inventor, issued by the USPTO.
  • The company is based in Maryland, U.S.A. Our website: www.igcinc.us .Twitter @IGCIR
    View source version on businesswire.com: https://www.businesswire.com/news/home/20200326005803/en/

Zoned Properties Reports Full-Year 2019 Financial Results

Thursday, March 26, 2020 - 8:05pm

Zoned Properties, Inc. (OTCQB: ZDPY), a strategic real estate development firm whose primary mission is to provide real estate and sustainability services for the regulated cannabis industry, positioning the Company for property acquisitions and revenue growth, today announced its financial results for the year ended December 31, 2019.

Key Points: 
  • Zoned Properties, Inc. (OTCQB: ZDPY), a strategic real estate development firm whose primary mission is to provide real estate and sustainability services for the regulated cannabis industry, positioning the Company for property acquisitions and revenue growth, today announced its financial results for the year ended December 31, 2019.
  • As a result, Zoned Properties closed 2019 with 11.9 million common shares issued and outstanding.
  • Zoned Properties closed 2019 with a tight capital structure, a clean balance sheet with no toxic debt, and a positive cash position, a rarity among companies operating in the regulated cannabis industry.
  • We very much look forward to sharing tangible updates as we work to grow Zoned Properties as an industry-wide leader.

VerdePharmHealth and Strain Genie Enter into a Multi-Year Group Purchasing Agreement for Cannabis DNA Testing & Personalized Genetic Analysis for Patients Nationwide

Thursday, March 26, 2020 - 12:45pm

VerdePharmHealth will leverage this strategic alliance with Strain Genie to further enhance our unique end-to-end solution and healthcare provider knowledge base via valuable genetic testing and personalized insights that affect cannabis use and patients health.

Key Points: 
  • VerdePharmHealth will leverage this strategic alliance with Strain Genie to further enhance our unique end-to-end solution and healthcare provider knowledge base via valuable genetic testing and personalized insights that affect cannabis use and patients health.
  • "We believe that partnering with VerdePharmHealth, an emerging leader in the medical cannabis space, offers the potential to significantly advance personalized cannabis DNA testing.
  • This exclusive GPO channel partnership further solidifies our mission of generating real-world evidence to accelerate and improve personalized DNA testing.
  • Strain Genie provides a genetic analysis service that looks at over 450 biomarkers to generate the worlds most comprehensive and personalized Cannabis Wellness Report.

ADS Biotec in Partnership With Kurabo (Japan) Launches SARS-CoV-2 Antibody Detection Kit for COVID-19

Wednesday, March 25, 2020 - 6:15pm

ADS Biotec is offering these test kits for the North American and European markets.

Key Points: 
  • ADS Biotec is offering these test kits for the North American and European markets.
  • ADS Biotecs new SARS-CoV-2 Antibody kits consist of two type of kits, detecting IgM and IgG antibodies of coronavirus in human blood samples.
  • The kits come complete with all required reagents, and are easy to use, providing qualitative visual interpretation within 15 minutes.
  • ADS Biotec has a global presence with development, sales, and support operations on three continents, and users in over 30 Countries.

Herbalife Nutrition’s Herbalife24 Triathlon, 5k and Bike Tour Event Rescheduled for October 25, 2020

Wednesday, March 25, 2020 - 1:00pm

Herbalife Nutrition (NYSE: HLF), a premier global nutrition company, today announced it has rescheduled the Herbalife24 Triathlon Los Angeles, 5k and Bike Tour for Sunday, October 25, 2020.

Key Points: 
  • Herbalife Nutrition (NYSE: HLF), a premier global nutrition company, today announced it has rescheduled the Herbalife24 Triathlon Los Angeles, 5k and Bike Tour for Sunday, October 25, 2020.
  • After careful consideration and consulting with health professionals, we have confirmed a new date for the event, said Ibi Montesino, senior vice president and managing director for North America, Herbalife Nutrition.
  • Through the Companys global campaign to eradicate hunger, Herbalife Nutrition is also committed to bringing nutrition and education to communities around the world.
  • Herbalife Nutrition also encourages investors to visit its investor relations website at ir.herbalife.com as financial and other information is updated, and new information is posted.

Medicine Man Technologies to Host Fourth Quarter 2019 Conference Call and Webcast on March 30, 2020

Wednesday, March 25, 2020 - 12:00pm

Medicine Man Technologies, Inc. (OTCQX: MDCL) ("Medicine Man Technologies" or "the Company") today announced that it will host its fourth quarter 2019 conference call and webcast on Monday, March 30, 2020 at 4:30 p.m.

Key Points: 
  • Medicine Man Technologies, Inc. (OTCQX: MDCL) ("Medicine Man Technologies" or "the Company") today announced that it will host its fourth quarter 2019 conference call and webcast on Monday, March 30, 2020 at 4:30 p.m.
  • Investors interested in participating in the conference call can dial 201-389-0879 or listen to the webcast from the Company's Investors website at https://ir.medicinemantechnologies.com .
  • Denver, Colorado-based Medicine Man Technologies (OTCQX: MDCL) is a rapidly growing provider of cannabis consulting services, nutrients, and supplies.
  • Current agreements will enable Medicine Man Technologies to offer cultivation, extraction, distribution and retail pharma-grade products.

Global Cannabidiol Market Study, 2020 - Applications, Manufacturers & Distributors, Prices, End-users, and Downstream Industry Trends - ResearchAndMarkets.com

Wednesday, March 25, 2020 - 11:24am

The "Cannabidiol (CAS 13956-29-1) Market Research Report 2020" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cannabidiol (CAS 13956-29-1) Market Research Report 2020" report has been added to ResearchAndMarkets.com's offering.
  • This global report is a result of industry experts' diligent work on researching the world market of Cannabidiol.
  • The report helps to build up a clear view of the market trends and development, identify major players in the industry, and estimate main downstream sectors.
  • The Cannabidiol global market report key points: